Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 84
Filter
1.
Food Res Int ; 173(Pt 1): 113265, 2023 11.
Article in English | MEDLINE | ID: mdl-37803578

ABSTRACT

Robots in manufacturing alleviate hazardous environmental conditions, reduce the physical/mental stress of the workers, maintain high precision for repetitive movements, reduce errors, speed up production, and minimize production costs. Although robots have pervaded many industrial sectors and domestic environments, the experiments in the food sectors are limited to pick-and-place operations and meat processing while we are assisting new attention in gastronomy. Given the great performances of the robots, there would be many other intriguing applications to explore which could usher the transition to precision food manufacturing. This review wants open thoughts and opinions on the use of robots in different food operations. First, we reviewed the recent advances in common applications - e.g. novel sensors, end-effectors, and robotic cutting. Then, we analyzed the use of robots in other operations such as cleaning, mixing/kneading, dough manipulation, precision dosing/cooking, and additive manufacturing. Finally, the most recent improvements of robotics in gastronomy with their use in restaurants/bars and domestic environments, are examined. The comprehensive analyses and the critical discussion highlighted the needs of further scientific understanding and exploitation activities aimed to fill the gap between the laboratory-scale results and the validation in the relevant environment.


Subject(s)
Robotics , Humans , Robotics/methods , Food Industry , Cooking , Restaurants
3.
Food Res Int ; 106: 666-676, 2018 04.
Article in English | MEDLINE | ID: mdl-29579973

ABSTRACT

3D printing technology was employed to obtain snacks with a designed cylindrical geometry from wheat flour dough enriched by ground larvae of Yellow mealworms (Tenebrio molitor) as novel source of proteins. The main microstructural features, overall quality, and nutritional attributes were studied as a function of formulation, time and temperature of baking. The addition of ground insects up to 20 g/100 g (d.b.) resulted in softer dough. This caused an overflow in dough deposition producing the increase in diameter, height and weight of snacks. Baking conditions did not alter the overall aspect of the snacks, but modification of the main dimensional and microstructure attributes were observed due to the better water evaporation. The optimization of baking conditions found that 22 min and 200 °C allowed obtaining a maximum desirability of 0.693. Baked in these conditions, the printed snacks enriched with 10 and 20% of ground insects significantly increased the total essential amino acid, from 32.5 (0% insects) to 38.2 and 41.3 g/100 g protein, respectively. The protein digestibility corrected amino acid score increased from 41.6 to 65.2 from 0 to 20% insect enrichment, with lysine and methionine + cysteine being the respective limiting amino acid. Our results evidenced the rational promotion of insects based on nutritional arguments and validated the use of 3D printing as technology to manufacture innovative printed snacks without adverse impact on technological quality.


Subject(s)
Dietary Proteins/analysis , Edible Grain/chemistry , Flour/analysis , Food Handling/methods , Food, Fortified/analysis , Insect Proteins/analysis , Nutritive Value , Printing, Three-Dimensional , Snacks , Tenebrio/chemistry , Triticum/chemistry , Amino Acids/analysis , Animals , Cooking , Dietary Proteins/standards , Digestion , Edible Grain/standards , Flour/standards , Food, Fortified/standards , Hot Temperature , Insect Proteins/standards , Protein Conformation , Quality Control
4.
Neuropharmacology ; 117: 134-148, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28163105

ABSTRACT

Nerve Growth Factor (NGF) is being considered as a therapeutic candidate for Alzheimer's disease. However, the development of an NGF-based therapy is limited by its potent pain activity. We have developed a "painless" derivative form of human NGF (NGF61/100), characterized by identical neurotrophic properties but a reduced nociceptive sensitization activity in vivo. Here we characterized the response of rat dorsal root ganglia neurons (DRG) to the NGF derivative NGF61/100, in comparison to that of control NGF (NGF61), analyzing the expression of noxious pro-nociceptive mediators. NGF61/100 displays a neurotrophic activity on DRG neurons comparable to that of control NGF61, despite a reduced activation of PLCγ, Akt and Erk1/2. NGF61/100 does not differ from NGF61 in its ability to up-regulate Substance P (SP) and Calcitonin Gene Related Peptide (CGRP) expression. However, upon Bradykinin (BK) stimulation, NGF61/100-treated DRG neurons release a much lower amount of SP and CGRP, compared to control NGF61 pre-treated neurons. This effect of painless NGF is explained by the reduced up-regulation of BK receptor 2 (B2R), respect to control NGF61. As a consequence, BK treatment reduced phosphorylation of the transient receptor channel subfamily V member 1 (TRPV1) in NGF61/100-treated cultures and induced a significantly lower intracellular Ca2+ mobilization, responsible for the lower release of noxious mediators. Transcriptomic analysis of DRG neurons treated with NGF61/100 or control NGF allowed identifying a small number of nociceptive-related genes that constitute an "NGF pain fingerprint", whose differential regulation by NGF61/100 provides a strong mechanistic basis for its selective reduced pain sensitizing actions.


Subject(s)
Nerve Growth Factor/adverse effects , Nerve Growth Factor/pharmacology , Pain/chemically induced , Peptide Fragments/adverse effects , Sensory Receptor Cells/cytology , Animals , Bradykinin/pharmacology , Calcitonin Gene-Related Peptide/metabolism , Calcium/metabolism , Ganglia, Spinal/metabolism , Gene Expression Profiling , Humans , Pain/metabolism , Peptide Fragments/pharmacology , Primary Cell Culture , Rats , Receptors, Bradykinin/metabolism , Substance P/metabolism , TRPV Cation Channels/metabolism , Up-Regulation/drug effects
5.
Cell Death Discov ; 2: 16050, 2016.
Article in English | MEDLINE | ID: mdl-27551538

ABSTRACT

A change in the delicate equilibrium between apoptosis and survival regulates the neurons fate during the development of nervous system and its homeostasis in adulthood. Signaling pathways promoting or protecting from apoptosis are activated by multiple signals, including those elicited by neurotrophic factors, and depend upon specific transcriptional programs. To decipher the rescue program induced by substance P (SP) in cerebellar granule neurons, we analyzed their whole-genome expression profiles after induction of apoptosis and treatment with SP. Transcriptional pathways associated with the survival effect of SP included genes encoding for proteins that may act as pharmacological targets. Inhibition of one of these, the Myc pro-oncogene by treatment with 10058-F4, reverted in a dose-dependent manner the rescue effect of SP. In addition to elucidate the transcriptional mechanisms at the intersection of neuronal apoptosis and survival, our systems biology-based perspective paves the way towards an innovative pharmacology based on targets downstream of neurotrophic factor receptors.

6.
J Food Sci Technol ; 53(1): 501-10, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26787969

ABSTRACT

Lack of nutrients in cooking water, high energetic costs, high water consumption and recycling are some drawbacks of vegetable blanching. Those disadvantages could be bypassed using microwave blanching. Three blanching methods (microwave, boiling water and steaming) were compared in this study in order to determine their effects on some functional properties of broccoli. In addition, the thermal damage on broccoli colour was evaluated. The effectiveness of each blanching process was performed measuring the lost of peroxidase activity, that results more rapidly in microwaves and steam treatments (50 and 60 s respectively) than in boiling water treatment (120 s). The colour indexes did not allow to discriminate a significant difference among treatments. The increase of treatment time caused a vitamin C decrease in samples blanched by boiling water and steam; this trend was not observed in microwaved samples. The phenols content did not significantly vary depending both on type and on time of treatment.

7.
J Agric Food Chem ; 63(8): 2321-7, 2015 Mar 04.
Article in English | MEDLINE | ID: mdl-25665600

ABSTRACT

The changes in chemical attributes and aromatic profile of espresso coffee (EC) were studied taking into account the extraction time and grinding level as independent variables. Particularly, using an electronic nose system, the changes of the global aromatic profile of EC were highlighted. The results shown as the major amounts of organic acids, solids, and caffeine were extracted in the first 8 s of percolation. The grinding grade significantly affected the quality of EC probably as an effect of the particle size distribution and the percolation pathways of water through the coffee cake. The use of an electronic nose system allowed us to discriminate the fractions of the brew as a function of the percolation time and also the regular coffee obtained from different grinding grades. Particularly, the aromatic profile of a regular coffee (25 mL) was significantly affected by the grinding level of the coffee grounds and percolation time, which are two variables under the control of the bar operator.


Subject(s)
Coffea/chemistry , Coffee/chemistry , Food Handling/methods , Volatile Organic Compounds/chemistry , Electronic Nose , Hot Temperature , Odorants/analysis , Particle Size
8.
Eur J Pharm Sci ; 52: 125-31, 2014 Feb 14.
Article in English | MEDLINE | ID: mdl-24215738

ABSTRACT

AIM: In this study we investigate in in vitro myometrial tissue samples of pregnant women: (a) the effects of proton pomp inhibitors (PPIs) (omeprazole, esomeprazole, pantoprazole, lansoprazole and rabeprazole) on spontaneous contractions; (b) the muscle-relaxant efficacy of the most active PPI considered (pantoprazole) in comparison with that of other known tocolytics (nifedipine, atosiban, MgSO4, isoxsuprine); (c) the effect of pantoprazole on contractions induced by calcium (Ca(++)), KCl, oxytocin and prostaglandin (PGE2); (d) the possible mediators of pantoprazole relaxant effect. METHODS: Organ bath studies were performed on myometrial tissue samples (40×10×10 mm) from pregnant women (38-42 weeks of gestational age) undergoing elective caesarian section. RESULTS: All the PPIs studied reduce the spontaneous contraction of the myometrial smooth muscle. Pantoprazole is the most effective and most potent inhibitor among those analyzed. Pantoprazole also reduces the contractions induced by Ca(++), KCl, oxytocin and PGE2. Neither NO, nor PGs, or the activation of Ca(++)-dependent K(+) currents mediate the muscle-relaxant effect of this PPI. CONCLUSION: These data, together with the fact that PPIs almost do not present side effects, suggest that these drugs can offer new therapeutic strategies for preterm delivery. Undoubtedly, further investigations and clinical studies are necessary before adding PPIs to the list of drugs available for the treatment of preterm delivery.


Subject(s)
2-Pyridinylmethylsulfinylbenzimidazoles/pharmacology , Myometrium/drug effects , Proton Pump Inhibitors/pharmacology , Tocolytic Agents/pharmacology , Apamin/pharmacology , Calcium/pharmacology , Dinoprostone/pharmacology , Esomeprazole/pharmacology , Female , Humans , In Vitro Techniques , Indomethacin/pharmacology , Lansoprazole/pharmacology , Muscle Contraction/drug effects , Myometrium/physiology , NG-Nitroarginine Methyl Ester/pharmacology , Omeprazole/pharmacology , Oxytocin/pharmacology , Pantoprazole , Peptides/pharmacology , Potassium Chloride/pharmacology , Pregnancy , Rabeprazole/pharmacology
9.
Peptides ; 36(1): 133-6, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22561241

ABSTRACT

The aims of this paper were to study: (1) the effects of TLQP-21 (non-acronic name), the C-terminal region of the VGF (non-acronic name), polypeptide (from residue 557 to 576 of VGF), on in vitro amylase release from rat isolated pancreatic lobules and acinar cells; (2) the mechanism through which TLQP-21 regulates exocrine pancreatic secretion, by using the muscarinic receptor antagonist atropine (10(-6)M) and the cyclo-oxygenase inhibitor, indomethacin (10(-6)M). On pancreatic lobules of rats, concentrations of TLQP-21 from 10(-7) to 10(-5)M significantly (p<0.05) induced a 2-3-fold increase of baseline pancreatic amylase release, measured at the end of 60 min incubation period. Co-incubation with atropine 10(-6)M did not antagonise the enzyme outflow induced by the peptide. On the contrary, co-incubation of TLQP-21 (10(-7) and 10(-6)M) with indomethacin, at concentration of 10(-6)M, which alone did not modify enzyme secretion, completely suppressed the increase of amylase evoked by TLQP-21 on pancreatic lobules. On rat pancreatic acinar cells, TLQP-21, at all the concentrations tested, was unable to affect exocrine pancreatic secretion, indicating an indirect mechanism of action on acinar cells. These results put in evidence, for the first time, that TLQP-21, a VGF-derived peptide, modulates exocrine pancreatic secretion in rats through a stimulatory mechanism involving prostaglandin release. In conclusion, TLQP-21 could be included among the neurohumoral signals regulating pancreatic exocrine secretion, and increases the knowledge concerning the systems controlling this function.


Subject(s)
Neuropeptides/chemistry , Pancreas, Exocrine/drug effects , Peptide Fragments/pharmacology , Acinar Cells/drug effects , Acinar Cells/enzymology , Acinar Cells/metabolism , Amylases/metabolism , Animals , Atropine/pharmacology , Cyclooxygenase Inhibitors/pharmacology , In Vitro Techniques , Indomethacin/pharmacology , Male , Muscarinic Antagonists/pharmacology , Pancreas, Exocrine/enzymology , Pancreas, Exocrine/metabolism , Rats , Rats, Wistar
10.
Neuropharmacology ; 62(5-6): 1954-63, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22244942

ABSTRACT

Altered levels of Substance P (SP), a neuropeptide endowed with neuroprotective and anti-apoptotic properties, were found in brain areas and spinal fluid of Alzheimer's disease (AD) patients. One of the hallmarks of AD is the abnormal extracellular deposition of neurotoxic beta amyloid (Aß) peptides, derived from the proteolytic processing of amyloid precursor protein (APP). In the present study, we confirmed, the neurotrophic action of SP in cultured rat cerebellar granule cells (CGCs) and investigated its effects on APP metabolism. Incubation with low (5 mM) potassium induced apoptotic cell death of CGCs and amyloidogenic processing of APP, whereas treatment with SP (200 nM) reverted these effects via NK1 receptors. The non-amyloidogenic effect of SP consisted of reduction of Aß(1-42), increase of sAPPα and enhanced α-secretase activity, without a significant change in steady-state levels of cellular APP. The intracellular mechanisms whereby SP alters APP metabolism were further investigated by measuring mRNA and/or steady-state protein levels of key enzymes involved with α-, ß- and γ-secretase activity. Among them, Adam9, both at the mRNA and protein level, was the only enzyme to be significantly down-regulated following the induction of apoptosis (K5) and up-regulated after SP treatment. In addition to its neuroprotective properties, this study shows that SP is able to stimulate non-amyloidogenic APP processing, thereby reducing the possibility of generation of toxic Aß peptides in brain.


Subject(s)
ADAM Proteins/metabolism , Amyloid Precursor Protein Secretases/metabolism , Amyloid beta-Protein Precursor/metabolism , Cerebellum/drug effects , Neurons/drug effects , Substance P/pharmacology , ADAM Proteins/genetics , Animals , Cells, Cultured , Cerebellum/cytology , Cerebellum/metabolism , Dose-Response Relationship, Drug , Neurons/cytology , Neurons/metabolism , Rats
11.
Crit Rev Food Sci Nutr ; 51(10): 955-64, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21955094

ABSTRACT

As is well known, pasteurization treatments are not sufficient for destroying heat resistance of spore forming microorganisms, which are prevented from germination and growing by pH reducing. So, the acidification process becomes one of the most important pre-treatments for the canning industry. It is commonly applied before pasteurization treatment with the purpose of inhibiting spore germination and for reducing heat resistance of the microorganism, thereby allowing to reduce the time or temperature values of the heat treatment. With the aim to reduce the pH of vegetables several techniques are available but their application is not easy to plan. Often, industries define operative conditions only on the basis of empirical experience, thus increasing the risk of microbial growth or imparting an unpleasant sour taste. With the aim of highlighting the correct plan and management of acidification treatments to reach safety without degrading quality of canned fruit and vegetables, the topics that are reviewed and discussed are the effects of low pH on heat resistance of the most important microorganisms, acidification techniques and significant process variables, the effect of low pH on sensorial properties, and future trends.


Subject(s)
Food Contamination/prevention & control , Food Handling/methods , Food, Preserved/analysis , Vegetables , Consumer Product Safety , Food Microbiology , Food Preservation/methods , Humans , Hydrogen-Ion Concentration , Pasteurization , Spores, Bacterial/growth & development , Temperature
12.
Acta Trop ; 119(1): 57-60, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21524640

ABSTRACT

Plasmodium vivax is still the more prevalent human Plasmodium outside Africa and despite this fact, there is still a deep lack of knowledge on its biology. Metacaspases are cysteine proteases related to metazoan caspases, involved in programmed cell death. Here, we have characterized the P. vivax metacaspase 1 gene in a total of 63 vivax isolates, 32 isolates collected in southern Iran and 31 Italian imported isolates originating from 12 different endemic countries. We have firstly identified DNA size polymorphism in P. vivax metacaspase 1 gene. A total of four different allelic sizes were found, resulting from the insertion of 1 to 4 tandem repeat units located within the intronic region of the P. vivax metacaspase 1. Similarly, we also have identified four distinct allelic types by using vivax merozoite surface protein-1 size polymorphism analysis.


Subject(s)
Caspase 1/genetics , Plasmodium vivax/genetics , Polymorphism, Genetic , Protozoan Proteins/genetics , Alleles , Base Sequence , Blood/parasitology , DNA, Protozoan/genetics , Genes, Protozoan , Humans , Introns , Iran , Italy , Merozoite Surface Protein 1/genetics , Molecular Sequence Data , Tandem Repeat Sequences
13.
Cell Death Differ ; 17(7): 1126-33, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20395961

ABSTRACT

The term trophic is widely used to indicate a general pro-survival action exerted on target cells by different classes of extracellular messengers, including neurotrophins (NTs), a family of low-molecular-weight proteins whose archetypal member is the nerve growth factor (NGF). The pro-survival action exerted by NTs results from a coordinated activation of multiple metabolic pathways, some of which have only recently come to light. NGF has been shown to exert a number of different, experimentally distinguishable effects on neurons, such as survival, differentiation of target neurons, growth of nerve fibers and their guidance (tropism) toward the source of its production. We have proposed a more complete definition of the NGF trophic action that should also include its newly discovered property of inhibiting the amyloidogenic processing of amyloid precursor protein (APP), which is among the first hypothesized primary trigger of Alzheimer's disease (AD) pathogenesis. This inhibitory action appears to be mediated by a complex series of molecular events and by interactions among NGF receptors (TrkA and p75), APP processing and tau metabolic fate and function.


Subject(s)
Amyloid beta-Protein Precursor/metabolism , Nerve Growth Factor/metabolism , Alzheimer Disease/metabolism , Animals , Apoptosis , Nerve Growth Factor/pharmacology , Nerve Growth Factors/pharmacology , Neurons/cytology , Neurons/metabolism , Rats , Receptor, trkA/metabolism , Receptor, trkA/physiology
14.
Neuropharmacology ; 58(1): 268-76, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19576909

ABSTRACT

The tachykinin endecapeptide substance P (SP) has been demonstrated to exert a functional role in neurodegenerative disorders, including Alzheimer's disease (AD). Aim of the present study was to evaluate the SP neuroprotective potential against apoptosis induced by the neurotoxic beta-amyloid peptide (A beta) in cultured rat cerebellar granule cells (CGCs). We found that SP protects CGCs against both A beta(25-35)- and A beta(1-42)-induced apoptotic CGCs death as revealed by live/dead cell assay, Hoechst staining and caspase(s)-induced PARP-1 cleavage, through an Akt-dependent mechanism. Since in CGCs the fast inactivating or A-type K(+) current (I(KA)) was potentiated by A beta treatment through up-regulation of Kv4 subunits, we investigated whether I(KA) and the related potassium channel subunits could be involved in the SP anti-apoptotic activity. Patch-clamp experiments showed that the A beta-induced increase of I(KA) current amplitude was reversed by SP treatment. In addition, as revealed by Western blot analysis and immunofluorescence studies, SP prevented the up-regulation of Kv4.2 and Kv4.3 channel subunits expression. These results indicate that SP plays a role in the regulation of voltage-gated potassium channels in A beta-mediated neuronal death and may represent a new approach in the understanding and treatment of AD.


Subject(s)
Amyloid beta-Peptides/pharmacology , Cerebellum/cytology , Neurons/drug effects , Shal Potassium Channels/metabolism , Substance P/pharmacology , Animals , Animals, Newborn , Biophysics , Caspase 3/metabolism , Cells, Cultured , Electric Stimulation , Ion Channel Gating/drug effects , Membrane Potentials/drug effects , Membrane Potentials/physiology , Oncogene Protein v-akt/metabolism , Patch-Clamp Techniques/methods , Peptide Fragments/pharmacology , Phosphorylation/drug effects , Rats , Rats, Wistar , Shal Potassium Channels/drug effects
15.
Br J Pharmacol ; 157(6): 984-93, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19466987

ABSTRACT

BACKGROUND AND PURPOSE: Vgf gene expression has been detected in various endocrine and neuronal cells in the gastrointestinal tract. In this study we investigated the pharmacological activity of different VGF-derived peptides. Among these, TLQP-21, corresponding to the 556-576 fragment of the protein was the unique active peptide, and its pharmacological profile was further studied. EXPERIMENTAL APPROACH: The effects of TLQP-21 were examined in vitro by smooth muscle contraction in isolated preparations from the rat gastrointestinal tract and, in vivo, by assessing gastric emptying in rats. Rat stomach tissues were also processed for immunohistochemical and biochemical characterization. KEY RESULTS: In rat longitudinal forestomach strips, TLQP-21 (100 nmol x L(-1)-10 micromol x L(-1)) concentration-dependently induced muscle contraction (in female rats, EC(50) = 0.47 micromol.L(-1), E(max): 85.7 +/- 7.9 and in male rats, 0.87 micromol x L(-1), E(max): 33.4 +/- 5.3; n = 8), by release of prostaglandin (PG)E(2) and PGF(2a) from the mucosal layer. This effect was significantly antagonized by indomethacin and selective inhibitors of either cyclooxygenase-1 (S560) or cyclooxygenase-2 (NS398). Immunostaining and biochemical studies confirmed the presence of VGF in the gastric neuronal cells. TLQP-21, injected i.c.v. (2-32 nmol per rat), significantly decreased gastric emptying by about 40%. This effect was significantly (P < 0.05) blocked by i.c.v. injection of indomethacin, suggesting that, also in vivo, this peptide acts in the brain stimulating PG release. CONCLUSIONS AND IMPLICATIONS: The present results demonstrate that this VGF-derived peptide plays a central and local role in the regulation of rat gastric motor functions.


Subject(s)
Gastrointestinal Motility/drug effects , Gastrointestinal Motility/physiology , Neuropeptides/pharmacology , Neuropeptides/physiology , Peptide Fragments/pharmacology , Peptide Fragments/physiology , Amino Acid Sequence , Animals , Female , Gastric Emptying/drug effects , Gastric Emptying/physiology , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/physiology , Male , Molecular Sequence Data , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Peptide Fragments/administration & dosage , Protein Precursors/administration & dosage , Protein Precursors/pharmacology , Protein Precursors/physiology , Rats , Rats, Wistar
16.
Pharmacol Res ; 59(3): 207-14, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19070664

ABSTRACT

The role of the cannabinoid system in the regulation of exocrine pancreatic secretion was investigated by studying the effects of the synthetic CB1- and CB2-receptors agonist, WIN55,212, on amylase secretion in isolated lobules and acini of guinea pig and rat, and the expression of CB-receptors in rat pancreatic tissue by immuno-chemistry and Western-blot analysis in both basal and cerulein (CK)-induced pancreatitis condition. In pancreatic lobules of guinea pig and rat, WIN55,212 significantly inhibited amylase release stimulated by KCl depolarization through inhibition of presynaptic acetylcholine release, but did not modify basal, carbachol- or CK-stimulated amylase secretion. The effect of WIN55,212 was significantly reduced by pre-treatment with selective CB1- and CB2-receptor antagonists. The antagonists, when given alone, did not affect the KCl-evoked response. Conversely, WIN55,212 was unable to affect basal and CK- or carbachol-stimulated amylase release from pancreatic acini of guinea pig and rat. Immunofluorescent staining of rat pancreatic tissues showed that CB1- and CB2-receptors are expressed in lobules and in acinar cells and their presence in acinar cells was also shown by Western-blot analysis. After CK-induced pancreatitis, the expression of CB1-receptors in acinar cells was not changed, whilst a down-regulation of CB2-receptors was observed. In conclusion, the present study shows that WIN55,212 inhibits amylase release from guinea pig and rat pancreatic lobules and, for the first time, that cannabinoid receptors are expressed in lobules of the rat pancreas, suggesting an inhibitory presynaptic role of this receptor system. Finally, in rat pancreatic acinar cells, CB1- and CB2-receptors, expressed both in basal conditions and after CK-induced pancreatitis but inactive on amylase secretion, have an unknown role both in physiological and pathological conditions.


Subject(s)
Pancreas, Exocrine/metabolism , Receptor, Cannabinoid, CB1/physiology , Receptor, Cannabinoid, CB2/physiology , Amylases/metabolism , Animals , Benzoxazines/pharmacology , Blotting, Western , Guinea Pigs , Male , Morpholines/pharmacology , Naphthalenes/pharmacology , Pancreas, Exocrine/chemistry , Pancreatitis/metabolism , Pancreatitis/pathology , Rats , Receptor, Cannabinoid, CB1/analysis , Receptor, Cannabinoid, CB2/analysis
17.
Neuropharmacology ; 52(6): 1366-77, 2007 May.
Article in English | MEDLINE | ID: mdl-17397881

ABSTRACT

In the current study, we have evaluated the ability of substance P (SP) and other neurokinin 1 receptor (NK1) agonists to protect, in a dose- and time-dependent manner, primary cultures of rat cerebellar granule cells (CGCs) from serum and potassium deprivation-induced cell death (S-K5). We also established the presence of SP high affinity NK1 transcripts and the NK1 protein localization in the membrane of a sub-population of CGCs. Moreover, SP significantly and dose-dependently reduced the Akt 1/2 and Erk1/2 dephosphorylation induced by S-K5 conditions, as demonstrated by Western blot analysis. Surprisingly, in SP-treated CGCs caspase-3 activity was not inhibited, while the calpain-1 activity was moderately reduced. Corroborating this result, SP blocked calpain-mediated cleavage of tau protein, as demonstrated by the reduced appearance of a diagnostic fragment of 17 kDa by Western blot analysis. In addition, SP induced a significant reduction of the delayed rectifier K+ currents (Ik) in about 42% of the patched neurons, when these were evoked with depolarizing potential steps. Taken together, the present results demonstrate that the activation of NK1 receptors expressed in CGCs promote the neuronal survival via pathways involving Akt and Erk activation and by inhibition of Ik which can contribute to the neuroprotective effect of the peptide.


Subject(s)
Cerebellum/drug effects , Delayed Rectifier Potassium Channels/physiology , Extracellular Signal-Regulated MAP Kinases/physiology , Mitogen-Activated Protein Kinases/physiology , Neuroprotective Agents , Substance P/pharmacology , Animals , Blotting, Western , Calpain/antagonists & inhibitors , Caspases/metabolism , Cerebellum/cytology , Cytoplasmic Granules/physiology , Delayed Rectifier Potassium Channels/drug effects , Electrophysiology , Enzyme Activation/drug effects , Immunohistochemistry , Microscopy, Phase-Contrast , Oncogene Protein v-akt/physiology , Patch-Clamp Techniques , Potassium/physiology , Rats , Rats, Wistar , Receptors, Neurokinin-1/drug effects , Receptors, Neurokinin-1/physiology , Reverse Transcriptase Polymerase Chain Reaction , Substance P/analogs & derivatives , Tachykinins/agonists
19.
Proc Natl Acad Sci U S A ; 103(39): 14584-9, 2006 Sep 26.
Article in English | MEDLINE | ID: mdl-16983076

ABSTRACT

The vgf gene has been identified as an energy homeostasis regulator. Vgf encodes a 617-aa precursor protein that is processed to yield an incompletely characterized panel of neuropeptides. Until now, it was an unproved assumption that VGF-derived peptides could regulate metabolism. Here, a VGF peptide designated TLQP-21 was identified in rat brain extracts by means of immunoprecipitation, microcapillary liquid chromatography-tandem MS, and database searching algorithms. Chronic intracerebroventricular (i.c.v.) injection of TLQP-21 (15 mug/day for 14 days) increased resting energy expenditure (EE) and rectal temperature in mice. These effects were paralleled by increased epinephrine and up-regulation of brown adipose tissue beta2-AR (beta2 adrenergic receptor) and white adipose tissue (WAT) PPAR-delta (peroxisome proliferator-activated receptor delta), beta3-AR, and UCP1 (uncoupling protein 1) mRNAs and were independent of locomotor activity and thyroid hormones. Hypothalamic gene expression of orexigenic and anorexigenic neuropeptides was unchanged. Furthermore, in mice that were fed a high-fat diet for 14 days, TLQP-21 prevented the increase in body and WAT weight as well as hormonal changes that are associated with a high-fat regimen. Biochemical and molecular analyses suggest that TLQP-21 exerts its effects by stimulating autonomic activation of adrenal medulla and adipose tissues. In conclusion, we present here the identification in the CNS of a previously uncharacterized VGF-derived peptide and prove that its chronic i.c.v. infusion effected an increase in EE and limited the early phase of diet-induced obesity.


Subject(s)
Diet/adverse effects , Energy Metabolism , Neuropeptides/metabolism , Obesity/chemically induced , Peptides/metabolism , Adipose Tissue, Brown/metabolism , Animals , Blood Glucose , Ghrelin , Glucose Tolerance Test , Ion Channels/genetics , Leptin/blood , Male , Mice , Mitochondrial Proteins/genetics , Nerve Growth Factors , Neuropeptides/chemistry , PPAR gamma/genetics , Peptide Hormones/blood , Peptides/chemistry , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptors, Adrenergic, beta/genetics , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Triglycerides/blood , Uncoupling Protein 1 , Up-Regulation/genetics
20.
Eur J Histochem ; 49(1): 87-92, 2005.
Article in English | MEDLINE | ID: mdl-15823799

ABSTRACT

We previously demonstrated that exogenously administered neurokinin A and neurokinin B, but not substance P, increased the sensitivity of cultured cerebellar granule neurons (CGNs) to glutamate. In the present study, the presence of tachykinin neuropeptides in CGNs was tested by confocal-based immunofluorescence. We found that neurokinin A and neurokinin B are present in CGNs but absent in astrocytes while substance P is abundant in astrocytes but absent in CGNs. It is postulated that the different localization of tachykinin neuropeptides in CGNs and astroglial cells has a physiological role in the modulation of excitatory transmission.


Subject(s)
Cerebellum/chemistry , Neurons/chemistry , Neuropeptides/analysis , Tachykinins/analysis , Animals , Antibody Specificity , Astrocytes/chemistry , Astrocytes/cytology , Astrocytes/metabolism , Cells, Cultured , Cerebellum/cytology , Cerebellum/metabolism , Cytoplasmic Granules , Fluorescent Antibody Technique , Immunohistochemistry , Microscopy, Confocal , Neurokinin A/analysis , Neurokinin A/biosynthesis , Neurokinin B/analysis , Neurokinin B/biosynthesis , Neurons/cytology , Neurons/metabolism , Neuropeptides/biosynthesis , Rats , Substance P/analysis , Substance P/biosynthesis , Tachykinins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...